Longeveron (LGVN) Equity Average (2022 - 2026)

Longeveron (LGVN) recorded quarterly Equity Average of $10.9 million in Q1 2026, up 38.75% quarter-over-quarter from $7.8 million in Q4 2025, and down 44.42% on a YoY basis from $19.5 million in Q1 2025.

Longeveron (LGVN) Equity Average (2022 - 2026) Analysis & Trends

Longeveron's Equity Average history runs 5 years deep, the most recent figure standing at $10.9 million for Q1 2026.

  • In Q1 2026, Equity Average fell 44.42% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (down 44.42% YoY), while the FY2025 annual figure was $13.8 million, down 3.72% from the prior year.
  • Equity Average was $10.9 million for Q1 2026 at Longeveron, up from $7.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $35.9 million in Q1 2022 to a low of $4.9 million in Q1 2024.
  • Historically, Equity Average has averaged $16.9 million across 5 years, with a median of $14.9 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Equity Average sank 73.43% in 2024, then jumped 299.15% in 2025.
  • A 5-year view of Equity Average shows it stood at $22.6 million in 2022, then slumped by 70.36% to $6.7 million in 2023, then surged by 255.3% to $23.8 million in 2024, then tumbled by 67.08% to $7.8 million in 2025, then jumped by 38.75% to $10.9 million in 2026.
  • The last three Equity Average figures came in at $10.9 million (Q1 2026), $7.8 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 3.50 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 783.14 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.76 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.01 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 21.35 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.01 Bn
9 Abivax 91.96 Bn 91.96 Bn - 516.41 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 10.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.85 Mn
Dec 31, 2025 7.82 Mn
Sep 30, 2025 11.31 Mn
Jun 30, 2025 14.91 Mn
Mar 31, 2025 19.52 Mn
Dec 31, 2024 23.76 Mn
Sep 30, 2024 20.27 Mn
Jun 30, 2024 8.98 Mn
Mar 31, 2024 4.89 Mn
Dec 31, 2023 6.69 Mn
Sep 30, 2023 8.95 Mn
Jun 30, 2023 13.79 Mn
Mar 31, 2023 18.41 Mn
Dec 31, 2022 22.56 Mn
Sep 30, 2022 27.00 Mn
Jun 30, 2022 31.84 Mn
Mar 31, 2022 35.88 Mn